Skip to main content
Market intelligence
FDMTHealthcare

4D Molecular Therapeutics Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 19, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 19, 2026David KirnSee RemarksSale69,076$15.75$1,088,272
Aug 17, 2026Scott BizilyChief Legal OfficerSale3,270$12.10$39,567
Aug 4, 2026David KirnSee RemarksSale26,842$10.23$274,596